ClinicalTrials.gg
WithdrawnNCT06398015Updated Jun 30, 2026

Hip Abductor Tendon Repair Versus Sham Surgery

An interventional study of Surgical reconstruction of hip abductor tendon tear and Sham surgery of hip abductor tendon tear in Rupture of Hip Abductor Tendon (Disorder), sponsored by Horsens Hospital. Withdrawn at 1 site in Denmark. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by Horsens Hospital · Not applicable, Interventional, and Treatment

How we know

Why this study was withdrawn
None of the screened potential participants were interested in participating.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
30 Years and older
Sex
All
01

Study summary

This study will examine the effectiveness of open surgical reconstruction in the treatment of patients with hip abductor tendon tears. Patients will be randomly allocated to either the open surgical reconstruction or to a open surgical sham procedure. The primary outcome is patient reported pain measured by the revised Copenhagen Hip And Groin Outcome Score (HAGOS), which will be conducted pre-surgery and at three and six months post-surgery. The six-month follow-up is the primary endpoint.

Read the detailed description

This is a study protocol for a Good Clinical Practice-monitored, double-blinded, randomized, controlled superiority trial with two groups, where the primary endpoint is differences in changes in lateral hip pain 6 months post-surgery. If included in the study, patients will be randomly allocated to one of the two arms:

  1. Open surgical reconstruction of the hip abductor tear (rHAT-group)
  2. Sham surgery (SHAM-group)

Patients will be allocated with a 1:1 ratio using permuted blocks with random varying sizes of 4, 6, and 8. An interim analysis will be performed when 8 patients in each group have completed the primary outcome assessment at 6 months.

Post-surgery, the patients in both groups will be guided and instructed in exercises according to their pain levels and functional capacity by an experienced physiotherapist blinded to the allocation. The first 6 post-surgery weeks, rehabilitation is home-based. After the 6-week follow-up, the patients will be referred to further rehabilitation in their home municipality (current standard practice).

The patients will be assessed pre-surgery, at 3 months post-surgery, and at the final follow-up at 6 months post-surgery. A physiotherapist blinded to the allocation will test the patients at the abovementioned timepoints.

In the trial paper all outcomes conducted will be published. That is, the primary outcome and the following secondary outcomes: The remaining five subscales of the revised HAGOS questionnaire (symptoms, function in daily living, function in sport and recreation, participation in physical activity, quality of life), Oxford Hip Score (OHS), European Questionnaire-5 Dimension (EQ-5D-5L and EQ-VAS), Global Rating of Change (GroC), Lateral hip pain on a numerical rating scale (NRS), The Victorian Institute of Sport Assessment-Gluteal Questionnaire (VISA-G), isometric hip abduction muscle strength, functional capacity by a 30 second Chair Stand Test (30s-CST).

The primary aim is to evaluate between-group changes on hip pain based on the subscale "pain" from the patient-reported outcome measure the revised Copenhagen Hip And Groin Outcome Score (HAGOS) from pre-surgery to 6 months post-surgery.

Primarily The primary hypothesis: The score in the subscale "pain" on the revised HAGOS will increase more in the intervention group compared to the control group, 6 months post-surgery.

A full study protocol will be published and made available.

02

Conditions studied

  • Rupture of Hip Abductor Tendon (Disorder)

Browse trials for

Keywords

  • orthopedics
  • hip injuries
  • rehabilitation
  • sham surgery
  • lateral hip pain
  • hip abductor tendon tear
03

In context

Hip Injuries

66 studies on the registry are indexed under Hip Injuries; 12 are open to participants now.

Browse Hip Injuries studies →

Lead sponsor

Horsens Hospital is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with an MRI verified hip abductor tendon pathology
  • Age 30 years or above
  • Lateral hip pain for more than 12 months
  • Ability to understand written and verbal Danish

Exclusion criteria

Exclusion Criteria:

  • Previous hip joint replacement, pelvic osteomies, hip abductor tendon surgery, femoral nailing or iliotibial band surgery
  • Pregnancy
  • Osteoarthritis of the hip joint on the affected side (Kellgren Lawrence grade +2)
  • Rheumatoid disorders
  • Inability to attend planned follow-up visits
  • Having an ongoing occupational injury insurance case
  • Expected lack of compliance due to cognitive issues, alcohol, or drug abuse
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    rHat-group

    Surgical reconstruction of hip abductor tendon tear

    Procedure: Surgical reconstruction of hip abductor tendon tear

  • Sham comparator
    SHAM-group

    Sham surgery of hip abductor tendon tear

    Procedure: Sham surgery of hip abductor tendon tear

Interventions

  • ProcedureSurgical reconstruction of hip abductor tendon tear

    If the patient is allocated to surgical reconstruction, the incision from the sham surgery is continued into the iliotibial band (ITB) and down to the hip abductor tendon complex/greater trochanter. A standardized reconstruction of the HAT with bone anchors is then performed. This standardized procedure has been used by the surgeons for the last 6 years. The ITB is then closed with looped suture, the subcutaneous tissue sutured with standard resorbable single sutures, the skin stapled and a standard wound dressing is applied.

  • ProcedureSham surgery of hip abductor tendon tear

    If the patient is allocated to sham surgery, the incision will only include the skin and subcutaneous tissue. Subsequently, the subcutaneous tissue will be sutured with standard resorbable single sutures, the skin stapled and a standard wound dressing applied. The patient will be kept in general anesthesia for 10 minutes after the procedure is finalized to mimic a true intervention (to hinder staff or relatives to comment on the duration of the procedure). The normal standard procedure takes approximately 40 minutes.

06

What researchers measure

Primary outcomes

  1. Differences in changes in patient-reported pain measured with the revised Copenhagen Hip And Groin Outcome Score (HAGOS) (continuous data)

    The subscale "pain" on HAGOS measures the patients perception of hip and/or groin pain. It consist of ten items. A score from 0 to 100 is calculated, where a higher score is indicating lower pain.

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

Secondary outcomes

  1. Differences in changes in patient-reported symptoms measured with the revised Copenhagen Hip And Groin Outcome Score (HAGOS) (continuous data)

    The subscale "symptoms" on HAGOS measures the patients perception of hip and/or groin pain. It consist of seven items. A score from 0 to 100 is calculated, where a higher score is indicating lower symptoms.

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

  2. Differences in changes in patient-reported physical function in daily living (ADL) measured with the revised Copenhagen Hip And Groin Outcome Score (HAGOS) (continuous data)

    The subscale "ADL" on HAGOS measures the patients perception of hip and/or groin pain. It consist of five items. A score from 0 to 100 is calculated, where a higher score is indicating higher function.

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

  3. Differences in changes in patient-reported physical function in sport and recreational activities (sport/recreation) measured with the revised Copenhagen Hip And Groin Outcome Score (HAGOS) (continuous data)

    The subscale "sport/recreation" on HAGOS measures the patients perception of hip and/or groin pain. It consist of eight items. A score from 0 to 100 is calculated, where a higher score is indicating higher function.

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

  4. Differences in changes in patient-reported participation in physical activities (PA) measured with the revised Copenhagen Hip And Groin Outcome Score (HAGOS) (continuous data)

    The subscale "PA" on HAGOS measures the patients perception of hip and/or groin pain. It consist of two items. A score from 0 to 100 is calculated, where a higher score is indicating higher ability to participate in physical activity.

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

  5. Differences in changes in patient-reported quality of life (QOL) measured with the revised Copenhagen Hip And Groin Outcome Score (HAGOS) (continuous data)

    The subscale "QOL" on HAGOS measures the patients perception of hip and/or groin pain. It consist of five items. A score from 0 to 100 is calculated, where a higher score is indicating higher quality of life.

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

  6. Differences in changes in the patient-reported outcome measure Oxford Hip Score (continuous data)

    Oxford Hip Score (OHS), which consists of 12items. OHS is developed and validated for patients undergoing total hip replacements to access pain and function. It is a composite score ranging from 0 (worst) to 48 (best).

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

  7. Differences in changes in the patient-reported outcome measure EQ-5D-5L (continuous data)

    European Questionnaire-5 Dimensions (EQ-5D-5L and EQ-VAS) consists of five items and a visual analogue score (VAS), a vertical line on which the patients score their perception of their overall health from 0 to 100 (worst to best)

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

  8. Global Rating of Change (GRoC)

    GRoC consists of a 11-point scale, where the patient rates the perceived overall change of the hip condition from "very much better" to "very much worse" . Responses on GRoC will be considered successful if patients scored "moderately better" to "very much better". Global improvement will be measured as the percentage of successful reports.

    Time frame: The outcome is conducted at 3- and 6-months post-surgery follow-up.

  9. Differences in changes in lateral hip pain on a numerical pain rating scale (NRS)

    Participants rate their pain on a scale from 0 (no pain) to 10 (worst imaginable). Participants will rate their average pain for the past 14 days during rest and activity.

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

  10. Differences in changes in the patient-reported outcome measure The Victorian Institute of Sport Assessment-Gluteal Questionnaire (VISA-G) (continuous data)

    The Victorian Institute of Sport Assessment-Gluteal Questionnaire (VISA-G) is validated for patients with gluteal tendinopathy and measures the severity of disability related to the condition. VISA-G consist of eight items and appraise the pain in relation to gluteal tendinopathy by a score from 0-100, where a higher score will indicate lower pain and less disability.

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

  11. Differences in changes of maximal isometric hip abduction muscle strength (continuous data)

    Maximal isometric hip abduction strength test measures the maximal voluntary isometric contraction in supine position. The strength will be measured using a fixed dynamometer. Strength will be conducted in Newton, but will be normalised according to the lever arm and body weight, and will be reported as Nm/kg bodyweight.

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

  12. Differences in changes of the number of repetitions of a 30 second sit to stand test (continuous data)

    Number of repetitions (sits to stand) performed during 30 seconds on a chair with a seat height of 46 cm.

    Time frame: From baseline to 6-months post-surgery follow-up. The outcome is also conducted at 3-months post-surgery follow-up.

07

Study locations

1 site
  • Horsens Regional Hospital
    Horsens, 8700, Denmark
08

References and documents

Individual participant data

Plan to share: Yes — What data will be shared: All quantitative individual participant data collected during the trial, after deidentification, and according to current Danish Data Protection Regulation and GDPR. With whom will data be shared: Researchers who provide a methodologically sound proposal. For what types of analyses: To achieve aims in the approved proposal. The abovementioned is based on Data Sharing Statements for Clinical Trial: A Requirement of the ICMJE located at: https://www.icmje.org/news-and-editorials/data_sharing_june_2017.pdf

Supporting information: Study protocol

Time frame: Immediately following publication and ending 5 years following primary article publication.

Access criteria: Proposals should be directed to mathhg@rm.dk. To gain access, data requestors will need to sign a data access agreement.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2024 to primary completion in Jun 2026, 25 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2024
First posted
May 3, 2024
StartActual
May 1, 2024
Primary completionActual
Jun 26, 2026
CompletionActual
Jun 26, 2026
Last update
Jun 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06398015
Lead sponsor
Horsens Hospital
Responsible party
Jeppe Lange (MD, PhD, Horsens Hospital) — Principal investigator
First posted
May 3, 2024
Start date
May 1, 2024
Primary completion
Jun 26, 2026
Completion
Jun 26, 2026
Last update
Jun 30, 2026

Study contacts

Mathias Høgsholt, PT, PhD.st.
principal investigator · Horsens Regional Hospital; Aarhus University
Jeppe Lange, MD, PhD
study director · Horsens Regional Hospital; Aarhus University
Signe Kierkegaard-Brøchner, PhD
study chair · Regionshospitalet Horsens
Kristian Thorborg, PhD
study chair · Copenhagen University Hospital, Hvidovre
Marie Bagger Bohn, MD, PhD
study chair · Regionshospitalet Horsens

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion